BOLD vs GPC · P/E 0.1, $24.6M cap vs P/E 21, rev $23.49B
Boundless Bio, Inc. Common Stock (BOLD) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Genuine Parts Co (GPC) is a auto parts company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the BOLD and GPC stock pages for the full models.
Not investment advice.